ITL Ltd (ITD) - Financial and Strategic SWOT Analysis Review

November 2017 | 45 pages | ID: IA0F289FFDDEN
GlobalData

Abstracts

ITL Ltd (ITD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Key manufacturing facilities – A list of key manufacturing facilities of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

ITL Ltd (ITL) is a medical device company. It develops, manufactures and markets medical and surgical devices, biological safety sampling devices and procedure packs for human and animal healthcare markets. The company offers products for blood banks, hospitals and laboratories, besides customized procedure packs; standardized procedure packs; sterile components; and monitoring kits and accessories. ITL also offers OEM products and custom healthcare devices according to clients’ specifications. The company through its subsidiary MyHealthTest Pty Ltd provides direct to consumer pathology testing for chronic diseases. The company has research and development and manufacturing facilities in Malaysia and Australia. It has marketing offices and subsidiaries in North America, Europe, Australia and Malaysia. The company offers its products in many countries the world over. ITL is headquartered in Victoria, Australia.

ITL Ltd Key Recent Developments

Jun 28,2017: ITL Achieves Record Month
Jun 13,2017: ITL Announces Positive Full Year Trading Update
Feb 27,2017: ITL Rebrands to ITL Health Group to Unify Divisions under a Global Brand
Feb 23,2017: ITL Profit Doubles In Half Year 2016/2017 Results
Aug 08,2016: ITL contract extended with bioMerieux

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

ITL Ltd - Key Facts
ITL Ltd - Key Employees
ITL Ltd - Key Employee Biographies
ITL Ltd - Major Products and Services
ITL Ltd - History
ITL Ltd - Company Statement
ITL Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

ITL Ltd - Business Description
ITL Ltd - Corporate Strategy
ITL Ltd - SWOT Analysis
SWOT Analysis - Overview
ITL Ltd - Strengths
ITL Ltd - Weaknesses
ITL Ltd - Opportunities
ITL Ltd - Threats
ITL Ltd - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

ITL Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017
ITL Ltd, Medical Equipment, Deals By Type, 2011 to YTD 2017
ITL Ltd, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Jul 11, 2017: MyHealthTest Participates in a World First Diabetes Prevention Program
Jun 28, 2017: MyHealthTest awarded $2.6m CRC Project Grant
Jun 28, 2017: ITL Achieves Record Month
Jun 13, 2017: ITL Announces Positive Full Year Trading Update
May 02, 2017: MyHealthTest Achieves Major Milestone of Laboratory Accreditation
Feb 27, 2017: ITL Rebrands to ITL Health Group to Unify Divisions under a Global Brand
Feb 23, 2017: ITL Profit Doubles In Half Year 2016/2017 Results
Nov 30, 2016: MyHealthTest wins Innovation Connection Grant
Aug 08, 2016: ITL contract extended with bioMerieux
Jun 08, 2016: ITL Announces CFO Changes

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

ITL Ltd, Key Facts
ITL Ltd, Key Employees
ITL Ltd, Key Employee Biographies
ITL Ltd, Major Products and Services
ITL Ltd, History
ITL Ltd, Other Locations
ITL Ltd, Subsidiaries
ITL Ltd, Key Competitors
ITL Ltd, Ratios based on current share price
ITL Ltd, Annual Ratios
ITL Ltd, Annual Ratios (Cont.1)
ITL Ltd, Annual Ratios (Cont.2)
ITL Ltd, Interim Ratios
ITL Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017
ITL Ltd, Medical Equipment, Deals By Type, 2011 to YTD 2017
ITL Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

ITL Ltd, Performance Chart (2013 - 2017)
ITL Ltd, Ratio Charts
ITL Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017
ITL Ltd, Medical Equipment, Deals by Type, 2011 to YTD 2017

COMPANIES MENTIONED

Ansell Limited
Mach7 Technologies Limited
Medical Australia Ltd
Unilife Corporation